Biological Therapy Analysis & Statistics, January 2013 (p9)

Talk to Amrita

+1 718 303 2019

All regions

You might be interested in: stem cell, cell therapy, tissue engineering, more »

241-270 of about 400 reports

Purchase Reports From Reputable Market Research Publishers

Global Brachytherapy Devices Market 2012-2016

Global Brachytherapy Devices Market 2012-2016

  • $ 2 500
  • Industry report
  • January 2013
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Brachytherapy Devices market to grow at a CAGR of 2.85 percent over the period 2012-2016. One of the key factors contributing to this market growth is the significant ...

  • Industries : Biological Therapy
  • Countries : World
The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in Japan

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the prefectures and cities of Japan. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : Japan
The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

The 2013-2018 Outlook for Cancer Therapy Pharmaceuticals in the United States

  • $ 495
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the latent demand outlook for cancer therapy pharmaceuticals across the states and cities of the United States. Latent demand (in millions of U.S. dollars), or potential industry ...

  • Industries : Biological Therapy
  • Countries : United States
The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

The 2013-2018 World Outlook for Cancer Therapy Pharmaceuticals

  • $ 795
  • Industry report
  • January 2013
  • by ICON Group

This econometric study covers the world outlook for cancer therapy pharmaceuticals across more than 200 countries. For each year reported, estimates are given for the latent demand, or potential industry ...

  • Industries : Biological Therapy
  • Countries : World
Fanconi Anemia - Pipeline Review, H2 2012

Fanconi Anemia - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Fanconi Anemia - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Fanconi Anemia - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
Adenovirus Infections - Pipeline Review, H2 2012

Adenovirus Infections - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • December 2012
  • by Global Markets Direct

Adenovirus Infections - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Adenovirus Infections - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity

  • $ 3 500
  • Industry report
  • December 2012
  • by GBI Research

Stem Cell Therapy Market in Asia-Pacific to 2018 - Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity Summary GBI Research, the leading business ...

  • Industries : Biological Therapy
  • Countries : South Korea
Global Tissue Engineering and Cell Therapy Market 2011-2015

Global Tissue Engineering and Cell Therapy Market 2011-2015

  • $ 2 000
  • Industry report
  • December 2012
  • by Infiniti Research Limited

TechNavio's analysts forecast the Global Tissue Engineering and Cell Therapy market to grow at a CAGR of 18 percent over the period 2011-2015. One of the key factors contributing to this market growth ...

  • Industries : Biological Therapy
  • Countries : World
Small-Molecule Targeted Cancer Therapies: World Market 2013-2023

Small-Molecule Targeted Cancer Therapies: World Market 2013-2023

  • $ 2 595
  • Industry report
  • December 2012
  • by Visiongain

Report Details Cancer treatment with small molecules - your guide to trends and revenue prospects What does the future hold for small targeted agents to treat cancers? Visiongain's updated report gives ...

  • Industries : Biological Therapy
  • Countries : World, United States
Stem Cell Research Products: Opportunities, Tools & Technologies

Stem Cell Research Products: Opportunities, Tools & Technologies

  • $ 2 995
  • Industry report
  • December 2012
  • by BioInformant Worldwide, L.L.C.

Stem cells are primitive cells found in all multi-cellular organisms that are characterized by self-renewal and the capacity to differentiate into any mature cell type. Several broad categories of stem ...

  • Industries : Biological Therapy
  • Countries : United States
Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)

Indian Stem Cell Banking Market: Trends & Opportunities (2012-2017)

  • $ 700
  • Industry report
  • December 2012
  • by Daedal Research

Today, stem cell banking is being witnessed as one of the most promising and emerging fields of life sciences. The stem cell banking market is further expected to witness increased significant growth as ...

  • Industries : Biological Therapy
  • Countries : India
Liver Cirrhosis - Pipeline Review, H2 2012

Liver Cirrhosis - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • November 2012
  • by Global Markets Direct

Liver Cirrhosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Liver Cirrhosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
Sezary Syndrome - Pipeline Review, H2 2012

Sezary Syndrome - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • November 2012
  • by Global Markets Direct

Sezary Syndrome - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Sezary Syndrome - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides ...

  • Industries : Biological Therapy
  • Countries : World
Sjogren%s Syndrome - Pipeline Review, H2 2012

Sjogren%s Syndrome - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • November 2012
  • by Global Markets Direct

Sjogren's Syndrome - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Sjogren's Syndrome - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report ...

  • Industries : Biological Therapy
  • Countries : World, United States
The Market for Stem Cell Research Products: Current and Future Opportunities

The Market for Stem Cell Research Products: Current and Future Opportunities

  • $ 3 200
  • Industry report
  • November 2012
  • by BioInformatics

The market for stem cell research products continues to flourish. As stem cell research begins to yield actionable therapies, companies are investing resources in this area of research that stands to revolutionize ...

  • Industries : Biological Therapy
Plasma Cell Neoplasm - Pipeline Review, H2 2012

Plasma Cell Neoplasm - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • October 2012
  • by Global Markets Direct

Plasma Cell Neoplasm - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Plasma Cell Neoplasm - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This ...

  • Industries : Biological Therapy
  • Countries : World
Primary Systemic Amyloidosis - Pipeline Review, H2 2012

Primary Systemic Amyloidosis - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • October 2012
  • by Global Markets Direct

Primary Systemic Amyloidosis - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Primary Systemic Amyloidosis - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic ...

  • Industries : Biological Therapy
  • Countries : World
Antisense Pharma GmbH - Product Pipeline Review - 2012

Antisense Pharma GmbH - Product Pipeline Review - 2012

  • $ 1 500
  • Company report
  • October 2012
  • by Global Markets Direct

Antisense Pharma GmbH - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Antisense Therapeutics Limited - Product Pipeline Review - 2012? provides data on the Antisense ...

  • Industries : Biological Therapy
  • Countries : World
Mesoblast Limited - Product Pipeline Review - 2012

Mesoblast Limited - Product Pipeline Review - 2012

  • $ 1 500
  • Company report
  • October 2012
  • by Global Markets Direct

Mesoblast Limited - Product Pipeline Review - 2012 Summary Global Market Direct's pharmaceuticals report, ?Mesoblast Limited - Product Pipeline Review - 2012? provides data on the Mesoblast Limited's ...

  • Industries : Biological Therapy
  • Countries : India, United States, World
Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)

Autologous Stem Cell and Non-Stem Cell Based Therapies Market (2012-2017) (Neurodegenerative, cardiovascular, cancer & autoimmune, skin and infectious diseases)

  • $ 4 650
  • Industry report
  • October 2012
  • by MarketsandMarkets

Autologous cell therapies are new therapeutic intervention where it introduces or uses cells or tissues from the individual, cultured, expanded and re-introduced at the site of the disease of the donor. ...

  • Industries : Biological Therapy
  • Countries : United States
Oxford BioTherapeutics Ltd - Medical Equipment - Deals and Alliances Profile

Oxford BioTherapeutics Ltd - Medical Equipment - Deals and Alliances Profile

  • $ 250
  • Company report
  • September 2012
  • by Global Data

Oxford BioTherapeutics Ltd - Medical Equipment - Deals and Alliances Profile Summary Oxford BioTherapeutics Ltd (Oxford BioTherapeutics) is a biopharmaceutical company, based in the UK. The company develops ...

  • Industries : Biological Therapy
Other Immunological Disorders - Pipeline Review, H2 2012

Other Immunological Disorders - Pipeline Review, H2 2012

  • $ 2 000
  • Company report
  • August 2012
  • by Global Markets Direct

Other Immunological Disorders - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Other Immunological Disorders - Pipeline Review, H2 2012', provides an overview of the Other Immunological Disorders ...

  • Industries : Biological Therapy
  • Countries : World, Australia
Genitope Corporation (GTOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Genitope Corporation (GTOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • $ 250
  • Company report
  • August 2012
  • by Global Data

Genitope Corporation (GTOP) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Summary Genitope Corporation (Genitope) is a publicly held US based biotechnology company. It is focused on the ...

  • Industries : Biological Therapy
  • Countries : United States
Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

Circulating Tumor Cells (Ctcs) And Cancer Stem Cells (Cscs) Market - Global Industry Size, Market Share, Trends, Analysis, And Forecasts 2012 - 2018

  • $ 2 795
  • Industry report
  • August 2012
  • by Transparency Market Research

Circulating tumor cell technology is an enabling technology for recovery and analysis of separated cancer cells in the peripheral blood. CTC technology offers advantages like high sensitivity, high specificity, ...

  • Industries : Biological Therapy
  • Countries : World
Emerging Pharmaceutical Technologies - Stem cells

Emerging Pharmaceutical Technologies - Stem cells

  • $ 3 900
  • Industry report
  • August 2012
  • by CBR Pharma Insights

Stem cell technology is set to play a significant role in the pharmaceutical industry of the future. The opportunities for using stem cells across drug discovery, disease research, drug development and ...

  • Industries : Biological Therapy
TiGenix NV (TIG) - Product Pipeline Analysis

TiGenix NV (TIG) - Product Pipeline Analysis

  • $ 750
  • Company report
  • August 2012
  • by Global Data

TiGenix NV (TIG) - Product Pipeline Analysis Summary TiGenix NV (TiGenix) is a publicly held biomedical cell therapy company. The company carries out the development of innovative local treatments fo ...

  • Industries : Biological Therapy
  • Countries : Finland, Belgium
Biological Therapy: Bioheart, Inc. (BHRT)

Biological Therapy: Bioheart, Inc. (BHRT)

  • $ 750
  • Company report
  • August 2012
  • by Global Data

This report is a source for data, analysis and actionable intelligence on the Bioheart, Inc. portfolio of new product development . The report provides detailed analysis on each pipeline product with ...

  • Industries : Biological Therapy
  • Countries : United States
Merger & Acquisition in Medical Equipment Industry: International Stem Cell Corporation (ISCO)

Merger & Acquisition in Medical Equipment Industry: International Stem Cell Corporation (ISCO)

  • $ 250
  • Company report
  • August 2012
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Biological Therapy
  • Countries : United States
World Biological Therapy: Brachytherapy Devices

World Biological Therapy: Brachytherapy Devices

  • $ 3 995
  • Industry report
  • August 2012
  • by Global Data

The report provides global industry value (USD million) for the two industry categories - permanent brachytherapy devices and temporary brachytherapy devices. The report is a key source for the current ...

  • Industries : Biological Therapy
  • Countries : World
Natural Killer Cell Lymphomas - Pipeline Review, H2 2012

Natural Killer Cell Lymphomas - Pipeline Review, H2 2012

  • $ 500
  • Company report
  • July 2012
  • by Global Markets Direct

Natural Killer Cell Lymphomas - Pipeline Review, H2 2012 Summary Global Markets Direct's, 'Natural Killer Cell Lymphomas - Pipeline Review, H2 2012', provides an overview of the Natural Killer Cell ...

  • Industries : Biological Therapy
  • Countries : United States, World

33 Companies

Read our Company Profiles

Bioheart Inc.

United States

StemCells Inc.

United States

GlaxoSmithKline P.L.C.

United States

Osiris Therapeutics Inc.

United States

Geron Corp.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.